跳至主要内容
临床试验/CTRI/2016/07/007081
CTRI/2016/07/007081尚未招募4 期

A Randomized Controlled Trial of Influenza Vaccine to Prevent Adverse Vascular Events - IVVE

McMaster University0 个研究点目标入组 3,500 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
入组人数
3,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • New York Heart Association(NYHA) functional class II, III and IV.

排除标准

  • a) Anaphylactic reaction to a previous dose of TIV.
  • b) Known IgE-mediated hypersensitivity to eggs manifested as hives, swelling of the mouth and throat, difficulty in breathing, hypotension, or shock.
  • c) Guillain-Barré syndrome within eight weeks of a previous influenza vaccine.
  • d) Anaphylactic reaction to neomycin.
  • e) Patients who have had influenza vaccine in two of the three previous years.
  • f) Patients with severe valvular disease that are candidates for surgical or percutaneous valve repair or replacement.

研究者

相似试验